MAP: XTX101 Monotherapy and/or Combination Therapy in Advanced Solid Tumors

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Managed Access Protocol for Patients with Advanced Solid Tumors who have Completed Protocol XTX101-01/02-001 (NCT04896697) Monotherapy Vilastobart (XTX101) and/or Combination Therapy Vilastobart and Atezolizumab and Continue to Receive Benefit from Treatment
Principal Investigator
Headshot of Nicholas Christian DeVito
Assistant Professor of Medicine
Protocol Number
IRB: PRO00120304
Phase
Phase N/A
Enrollment Status
OPEN TO ACCRUAL